Back to mobile site
Get it on Google Play

BriaCell receives fourth positive safety board recommendation for phase 3 study

October 22, 2025 7:30 AM EDT Send to a Friend
BriaCell Therapeutics Corp. (NASDAQ: BCTX) (TSX: BCT) announced that an independent Data Safety Monitoring Board issued its fourth consecutive positive ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login